常染色体显性多囊肾病的心血管并发症
本文综述了常染色体显性多囊肾病(ADPKD)的心血管并发症,指出心血管疾病是ADPKD患者的主要死亡原因并伴高合并症负担。心血管表现包括高血压、左心室肥厚、舒张功能障碍、瓣膜异常、主动脉瘤和心包积液,可早期出现或随慢性肾脏病进展而出现。早期检测对改善管理至关重要,本文还简要概述了量身定制的管理方法。
要点
- 心血管疾病是ADPKD患者的主要死亡原因,合并症负担高。
- 心血管表现包括高血压、左心室肥厚、舒张功能障碍、瓣膜异常、主动脉瘤和心包积液。
- 早期检测心血管表现对优化ADPKD患者管理具有关键作用。
核心结论
- 心血管疾病是ADPKD患者的主要死亡原因,早期检测心血管表现对改善管理至关重要。
研究设计与样本
- 本文为综述,探讨ADPKD的心血管并发症,强调早期检测的必要性,并简要概述量身定制的管理方法。
主要发现
- ADPKD的心血管表现包括高血压(可导致左心室肥厚和舒张功能障碍)、瓣膜异常、主动脉瘤和心包积液。
- ADPKD中的高血压可能始于早年,由多囊蛋白功能障碍、细胞内信号传导破坏和肾素-血管紧张素-醛固酮系统激活的复杂相互作用驱动,可导致血管结构改变和内皮功能受损。
- 瓣膜受累呈现年龄分布的双峰模式,早期表现在年轻患者中可能与遗传因素有关,晚期并发症则随CKD进展而出现。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autosomal dominant polycystic kidney disease (ADPKD), primarily caused by mutations in the PKD1 or PKD2 gene, is among the most common hereditary kidney diseases worldwide and is associated with significant extrarenal manifestations, including cardiovascular disease. In patients with ADPKD, cardiovascular disease is the major cause of mortality and is associated with a high burden of comorbidities. Cardiovascular manifestations include hypertension, which may lead to left ventricular hypertrophy (LVH) and diastolic dysfunction, as well as valvular abnormalities, aortic aneurysm, and pericardial effusion (PCE). The cardiovascular manifestations can present early as part of the ADPKD manifestation or later because of chronic kidney disease (CKD) progression. Early detection of cardiovascular manifestations can play a pivotal role in better management of these patients. Hypertension in ADPKD might start at an early age and is driven by a complex interplay of polycystin (PC) dysfunction, intracellular signaling disruptions, and activation of the renin-angiotensin-aldosterone system (RAAS), which can contribute to vascular structural changes and impaired endothelial function. Valvular involvement exhibits a bimodal pattern of age distribution, with early manifestations occurring in younger patients likely linked to genetic factors and later complications emerging as part of CKD progression. This review explores cardiovascular complications in ADPKD, emphasizing the need for early detection, and briefly provides an overview of tailored management approaches to improve outcomes in this high-risk population.
引用
- Ebrahimi N, Caliskan Y, Garimella PS, et al. Cardiovascular Complications in ADPKD. Kidney Int Rep. 2025. PMID: 40980664. doi:10.1016/j.ekir.2025.06.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。